Robert Huang, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 3 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
11 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Huang’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A122152 · Current
Licensed to practise in California · since 2012 · expires 2027-11-30 · Duke University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$69,931
Medicare paid this office $69,931 for 218 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 12 | $6,259 | $391 |
| Return visit (30+ min) | 42 | $5,502 | $100 |
| Long return visit (40+ min) | 27 | $4,849 | $147 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 36 | $4,428 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $3,501 | $106 |
See all 14 services
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 12 | $6,259 | $391 |
| Return visit (30+ min) | 42 | $5,502 | $100 |
| Long return visit (40+ min) | 27 | $4,849 | $147 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 36 | $4,428 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $3,501 | $106 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | $3,317 | $237 |
| New patient visit (45+ min) | 28 | $2,914 | $104 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 37 | $2,525 | $68 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 11 | $1,568 | $131 |
| Short return visit (20+ min) | 13 | $1,074 | $72 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,020 | $93 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $879 | $73 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 28 | $707 | $20 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 31 | $146 | $5 |
Procedures Medicare counted
| Colonoscopy | 53 | More than 65% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 233 | More than 92% of doctors who do this |
Who their Medicare patients are
218 Original Medicare patients in 2024. Average age 73 · Under 65 8% · 85 and older 10% · Women 51% · Also on Medicaid 31% · Health risk score 1.75. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 70% · Diabetes 36% · Coronary heart disease 27% · Chronic kidney disease 27% · Cancer 26% · Depression 21% · Heart failure 20% · Atrial fibrillation 18% · COPD 13% · Dementia 12% · Stroke 11%.
The office billed $761,002, Medicare allowed $90,148 and paid $69,931; for 583 services of 62 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 218 | 583 | 73 | 1.75 | $761,002 | $69,931 |
| 2023 | 244 | 657 | 72 | 2.55 | $801,195 | $83,346 |
| 2022 | 235 | 598 | 73 | 2.28 | $721,481 | $77,228 |
| 2021 | 166 | 483 | 72 | 1.98 | $652,587 | $63,132 |
| 2020 | 137 | 429 | 73 | 2.23 | $514,861 | $54,035 |
| 2019 | 167 | 409 | 73 | 2.08 | $424,869 | $49,230 |
| 2018 | 86 | 244 | 73 | 1.99 | $233,999 | $29,700 |
| 2017 | 25 | 50 | 73 | 2.38 | $36,712 | $4,779 |
| 2016 | 45 | 86 | 78 | 2.77 | $26,214 | $6,907 |
| 2015 | 34 | 59 | 79 | 1.80 | $18,753 | $4,998 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $8,275 | $109 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 16 | $6,849 | $403 |
| Replacement of stent in pancreatic or bile duct using a flexible endoscope | 14 | $6,269 | $418 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 50 | $5,979 | $117 |
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 32 | $5,773 | $180 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 24 | $5,417 | $201 |
| Return visit (30+ min) | 43 | $4,247 | $77 |
| New patient visit (45+ min) | 28 | $3,162 | $113 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 29 | $2,623 | $87 |
| Incision of pancreatic outlet using a flexible endoscope | 17 | $2,590 | $152 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 20 | $2,560 | $128 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $1,755 | $110 |
| Long return visit (40+ min) | 11 | $1,439 | $120 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 54 | $1,335 | $22 |
| Short return visit (20+ min) | 11 | $610 | $55 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 18 | $86 | $5 |
2022: 15 services
| Replacement of stent in pancreatic or bile duct using a flexible endoscope | 17 | $13,205 | $413 |
| Return visit (30+ min) | 58 | $7,004 | $83 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 12 | $5,313 | $354 |
| New patient visit (45+ min) | 39 | $4,470 | $115 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,920 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $3,864 | $90 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 35 | $3,330 | $90 |
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 19 | $3,233 | $170 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 19 | $2,824 | $149 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 13 | $2,310 | $165 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,873 | $156 |
| Diagnostic exam of small bowel (excluding lower small intestine) using an endoscope | 11 | $1,270 | $115 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,251 | $104 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 36 | $1,177 | $22 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 20 | $96 | $5 |
2021: 13 services
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 15 | $7,901 | $416 |
| Replacement of stent in pancreatic or bile duct using a flexible endoscope | 11 | $5,545 | $427 |
| Return visit (30+ min) | 33 | $3,564 | $87 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 22 | $3,328 | $151 |
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 18 | $3,042 | $169 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $3,007 | $125 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 37 | $2,811 | $72 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 16 | $2,582 | $129 |
| Short return visit (20+ min) | 19 | $1,316 | $60 |
| New patient visit (45+ min) | 12 | $1,277 | $106 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 33 | $1,271 | $28 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $1,014 | $92 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 16 | $73 | $5 |
2020: 11 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $3,311 | $127 |
| Return visit (30+ min) | 29 | $2,685 | $71 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 29 | $2,502 | $83 |
| New patient visit (45+ min) | 20 | $2,252 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,238 | $97 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 11 | $1,864 | $143 |
| Long return visit (40+ min) | 18 | $1,759 | $98 |
| Diagnostic exam of small bowel (excluding lower small intestine) using an endoscope | 11 | $1,647 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,418 | $68 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 27 | $1,213 | $34 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 11 | $50 | $5 |
2019: 10 services
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 21 | $3,703 | $161 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,659 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $3,187 | $64 |
| New patient visit (45+ min) | 21 | $2,165 | $103 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,611 | $90 |
| Return visit (30+ min) | 18 | $1,329 | $70 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,175 | $73 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 28 | $1,127 | $32 |
| Short return visit (20+ min) | 12 | $770 | $45 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 15 | $72 | $5 |
2018: 5 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,300 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $3,072 | $65 |
| New patient visit (45+ min) | 11 | $1,255 | $114 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 16 | $611 | $32 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 13 | $62 | $5 |
2017: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $906 | $65 |
2016: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $2,981 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,782 | $65 |
2015: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $3,098 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,241 | $65 |
Drugs they prescribed that Part D paid
$7,949
Pharmacies billed $7,949 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 147) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
129 generic and 18 brand-name prescriptions · $7,949 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mesalamine Dr | 12 | $3,656 | $305 |
| Gavilyte-G | 22 | $318 | $14 |
| Peg 3350-Electrolyte | 16 | $277 | $17 |
| Famotidine | 25 | $126 | $5 |
Year by year
| 2024 | 147 | 72 | 0% (0) | 12% | $7,949 |
| 2023 | 89 | 46 | 0% (0) | 17% | $8,643 |
| 2022 | 167 | 60 | None | 21% | $45,931 |
| 2021 | 99 | 41 | None | 19% | $7,776 |
| 2020 | 68 | 34 | 0% (0) | None | $9,503 |
| 2019 | 70 | 35 | None | None | $4,126 |
| 2018 | 31 | 19 | 0% (0) | None | $1,057 |
| 2017 | 24 | 12 | 0% (0) | 50% | $7,768 |
| 2016 | 32 | None | None | 63% | $7,620 |
| 2013 | 18 | None | None | 0% | $271 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Mesalamine Dr | 12 | $3,656 | $305 |
| Gavilyte-G | 14 | $237 | $17 |
2022: 4 drugs
| Ursodiol | 18 | $6,700 | $372 |
| Mesalamine Dr | 11 | $3,668 | $333 |
| Omeprazole | 22 | $453 | $21 |
| Pantoprazole | 21 | $238 | $11 |
2021: 3 drugs
| Peg 3350-Electrolyte | 12 | $249 | $21 |
| Amitriptyline | 14 | $112 | $8 |
| Omeprazole | 14 | $67 | $5 |
2020: 2 drugs
| Gavilyte-G | 12 | $214 | $18 |
| Omeprazole | 18 | $112 | $6 |
2019: 2 drugs
| Cholestyramine | 19 | $2,901 | $153 |
| Gavilyte-G | 17 | $246 | $14 |
2016: 1 drug
| Amitiza | 13 | $2,170 | $167 |
Money from drug and device companies
$322 in 2025
| 2025 | 2 | 3 | None | $322 |
| 2022 | 2 | 2 | None | $110 |
| 2021 | 1 | 1 | None | $156 |
| 2020 | 1 | 1 | None | $145 |
| 2019 | 1 | 1 | None | $55 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Exalt Model D | $293 | 2 payments
|
| Mauna Kea Technologies | None | $29 | 1 payment
|
See all 3 published payments
| Mauna Kea Technologies | Meals · 2025-07-21 | None | $29 |
| Boston Scientific | Meals · 2025-06-19 | Axios | $143 |
| Boston Scientific | Meals · 2025-05-04 | Exalt Model D | $150 |
See earlier years (2022, 2021, 2020, 2019)
2022: $110
| Medtronic | Gi Genius | $59 | 1 payment
|
| Boston Scientific | Exalt Model D | $51 | 1 payment
|
2021: $156
| Lumendi | Dilumen | $156 | 1 payment
|
2020: $145
| Lumendi | Dilumen | $145 | 1 payment
|
2019: $55
| Olympus America | Olympus Emr & Esd Devices | $55 | 1 payment
|
Professional record
- NPI
- 1528359593
- Licence
- CA A122152California A122152: Current · expires 2027-11-30
- Trained
- Duke University School of Medicine, 2011
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Drive,, Grant S101, Stanford, CA, 94305
- NPI first listed
- 2011-04-26
- NPI last updated
- 2024-04-26
- NPI record certified
- 2024-04-26
This is when the NPI record was last certified, not a medical board exam.